What is CalmWave?
CalmWave operates at the intersection of healthcare technology and artificial intelligence, providing a specialized platform designed to optimize medical device alarm parameters. By utilizing transparent AI, the company processes complex hospital data to filter out inactionable alerts, thereby allowing clinical staff to prioritize critical patient care. This market position is increasingly vital as hospitals face mounting pressure to reduce operational noise and enhance the precision of their monitoring systems.
The company's core value proposition lies in its ability to integrate seamlessly with existing hospital workflows, transforming raw data into actionable clinical intelligence. As healthcare providers seek to improve efficiency and reduce burnout, CalmWave's technology serves as a foundational tool for modernizing the clinical environment through data-driven decision support.
How much funding has CalmWave raised?
CalmWave has raised a total of $13.7M across 3 funding rounds:
Angel/Seed
$4M
Other Financing Round
$5.3M
Other Financing Round
$4.4M
Angel/Seed (2022): $4M with participation from Tau Ventures, Seachange Ventures, Bonfire Ventures, and Hike Ventures
Other Financing Round (2024): $5.3M led by Bonfire Ventures, Catalyst Pharmaceuticals, Impulsum, Third Prime, Rebellion Group Holdings, and Silver Circle
Other Financing Round (2025): $4.4M supported by Bonfire Ventures, Wellstar, and Third Prime
Key Investors in CalmWave
Bonfire Ventures
Bonfire Ventures is a lead investor specialized in funding ambitious B2B software startups at the seed stage, focusing on delivering responsive and personalized support to founders.
Third Prime
Third Prime is a prominent early-stage venture capital firm that emphasizes partnership and independent thinking, concentrating resources on accelerating paradigm shifts for their portfolio companies.
Wellstar
Catalyst by Wellstar is an innovative healthcare venture fund that focuses on transforming the healthcare system by investing in solutions that promote healthier communities and improve patient outcomes.
What's next for CalmWave?
With this latest capital injection, CalmWave is well-positioned to accelerate its product development roadmap and expand its footprint within the enterprise healthcare sector. The strategic focus will likely shift toward scaling its AI-driven alarm optimization platform to accommodate larger hospital networks and complex multi-facility health systems.
Furthermore, the involvement of specialized healthcare investors suggests a move toward deeper integration with clinical workflows and potential expansion into predictive analytics. As the company matures, it will likely prioritize the refinement of its machine learning models to ensure higher accuracy and broader compatibility with diverse medical device manufacturers, solidifying its role as an essential partner in the future of digital health.
